Purchase Order 75N91022P00778

Award Date 9/1/22
Potential Completion Date 8/31/23
Potential Value $157K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Potomac, MD 20850, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm fixed-price purchase order contract was awarded by the National Cancer Institute (NCI) to Becton, Dickinson and Company (BD) for maintenance services on various government-owned BD flow cytometry equipment. The $1,994,840.77 contract has a period of performance through July 1, 2026. No set-aside designation was used. BD, a global medical technology company, has extensive experience providing specialized equipment and consumables to support biomedical research and clinical programs...
This is a firm fixed-price purchase order awarded by the Department of Health and Human Services' (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Becton, Dickinson And Company (BD) for a service agreement to maintain BD flow cytometers and lasers. The $32,457.45 contract has a period of performance from November 21, 2022 to April 21, 2023 and does not include a set-aside designation. BD, a global medical technology company, will...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm fixed-price purchase order to Becton, Dickinson and Company (BD), a global medical technology company, for preventive maintenance, emergency service, support, and coverage for four government-owned BD Biosciences flow cytometry instruments. The one-year contract with four option years, valued at $148,833.48, provides for semi-annual preventive maintenance, on-site emergency repair...
This is a sole-source, firm-fixed-price purchase order awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), to Becton, Dickinson and Company (BD) for preventive maintenance services on a government-owned BD LSRFortessa Flow Cytometer. The contract has an initial one-year period of performance with four 12-month option periods, and a total ceiling value of $144,941.40. BD, the original equipment...
This is a firm fixed-price purchase order awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Becton, Dickinson and Company (BD) for renewal maintenance services on BD flow cytometers. The potential value of the contract is $286,607.40 with a period of performance from April 1, 2024 to March 31, 2025. The contract is for preventative maintenance inspections, software/parts updates, and on-site service...
This is a firm-fixed price purchase order for maintenance and repair services on six BD Biosciences flow cytometry instruments owned by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH) under the Department of Health and Human Services (HHS). The $257,078.10 contract was awarded to Becton, Dickinson and Company (BD), the original manufacturer and sole authorized service provider for the specialized instruments. The services include preventative maintenance,...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases, a civilian agency, to Becton, Dickinson and Company (BD) for maintenance services on various BD flow cytometers and lasers. The contract has a ceiling value of $295,042.20 and an ultimate completion date of March 31, 2026. The contract was awarded on April 1, 2025 and there was no set-aside designation used. BD Biosciences, a division of BD, will be providing the maintenance...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, to Becton, Dickinson and Company (BD) for a one-year extended warranty and maintenance kit for a C6 flow cytometer and CsAmpler, critical laboratory equipment used in biomedical research. The total ceiling value of the order is $21,204.00. BD, a leading manufacturer of medical devices and diagnostic products, has received...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for an annual maintenance agreement on two flow cytometers. The contract has a ceiling value of $7,068.00 and an ultimate completion date of January 30, 2016. BD is a major manufacturer and supplier of medical devices, instruments, reagents, and related products to government agencies,...
This is a firm-fixed price purchase order awarded by the Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases to Becton, Dickinson And Company (BD) for an annual service contract for BD equipment. The contract is valued at $132,192.48 and runs from January 27, 2022 to January 31, 2023. The contract is for the provision of full service coverage, including replacement parts, labor, and travel, for various flow cytometry...

This is a firm-fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute (NCI) to Becton, Dickinson and Company (BD) for preventive maintenance services on four government-owned BD Biosciences flow cytometry instruments. The contract is valued at $156,957.12 and has a period of performance from September 1, 2022 to August 31, 2023. There is no set-aside designation for this award. BD is the prime contractor and will provide the required preventive maintenance, emergency repair services, software updates, and other support to maintain the critical research instruments used in NCI biomedical research programs. As a leading global medical technology company, BD is uniquely positioned to service these specialized BD Biosciences flow cytometers.

Generated 3/22/24, 11:13 PM